Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M F Good

Showing results (121-130 of 155) with videos related to

Pageof 16
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1988
Parasite polymorphism present within minimal T cell epitopes of Plasmodium falciparum circumsporozoite proteinM F Good, D Pombo, W L Maloy, et al.
International Immunology|May 14, 1999
Functional analysis of IgA antibodies specific for a conserved epitope within the M protein of group A streptococci from Australian Aboriginal endemic communitiesE R Brandt, W A Hayman, B Currie, et al.
Journal of Virology|April 1, 1993
Protection of sheep against bovine leukemia virus (BLV) infection by vaccination with recombinant vaccinia viruses expressing BLV envelope glycoproteins: correlation of protection with CD4 T-cell response to gp51 peptide 51-70M H Gatei, H M Naif, S Kumar, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1988
Lack of cross-reactivity between variant T cell determinants from malaria circumsporozoite proteinV F de la Cruz, W L Maloy, L H Miller, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1988
Recombinant human IL-2 overcomes genetic nonresponsiveness to malaria sporozoite peptides. Correlation of effect with biologic activity of IL-2M F Good, D Pombo, M N Lunde, et al.
Scandinavian Journal of Immunology. Supplement|January 1, 1992
Development of a malaria T-cell vaccine for blood stage immunityI A Quakyi, D W Taylor, A H Johnson, et al.
Antimicrobial Agents and Chemotherapy|September 29, 2005
Lengthy antimalarial activity of atovaquone in human plasma following atovaquone-proguanil administrationM D Edstein, B M Kotecka, K L Anderson, et al.
International Immunology|October 3, 2001
Antibody levels to the class I and II epitopes of the M protein and myosin are related to group A streptococcal exposure in endemic populationsE R Brandt, P J Yarwood, D J McMillan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 8, 1997
Complete protective immunity induced in mice by immunization with the 19-kilodalton carboxyl-terminal fragment of the merozoite surface protein-1 (MSP1[19]) of Plasmodium yoelii expressed in Saccharomyces cerevisiae: correlation of protection with antigen-specific antibody titer, but not with effector CD4+ T cellsC Hirunpetcharat, J H Tian, D C Kaslow, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|September 1, 1990
Recognition of dominant T cell-stimulating epitopes from the circumsporozoite protein of Plasmodium falciparum and relationship to malaria morbidity in Gambian childrenE M Riley, S J Allen, S Bennett, et al.
Pageof 16

Showing results (121-130 of 155) with videos related to

Sort By:
Pageof 16
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1988
Parasite polymorphism present within minimal T cell epitopes of Plasmodium falciparum circumsporozoite proteinM F Good, D Pombo, W L Maloy, et al.
International Immunology|May 14, 1999
Functional analysis of IgA antibodies specific for a conserved epitope within the M protein of group A streptococci from Australian Aboriginal endemic communitiesE R Brandt, W A Hayman, B Currie, et al.
Journal of Virology|April 1, 1993
Protection of sheep against bovine leukemia virus (BLV) infection by vaccination with recombinant vaccinia viruses expressing BLV envelope glycoproteins: correlation of protection with CD4 T-cell response to gp51 peptide 51-70M H Gatei, H M Naif, S Kumar, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1988
Lack of cross-reactivity between variant T cell determinants from malaria circumsporozoite proteinV F de la Cruz, W L Maloy, L H Miller, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1988
Recombinant human IL-2 overcomes genetic nonresponsiveness to malaria sporozoite peptides. Correlation of effect with biologic activity of IL-2M F Good, D Pombo, M N Lunde, et al.
Scandinavian Journal of Immunology. Supplement|January 1, 1992
Development of a malaria T-cell vaccine for blood stage immunityI A Quakyi, D W Taylor, A H Johnson, et al.
Antimicrobial Agents and Chemotherapy|September 29, 2005
Lengthy antimalarial activity of atovaquone in human plasma following atovaquone-proguanil administrationM D Edstein, B M Kotecka, K L Anderson, et al.
International Immunology|October 3, 2001
Antibody levels to the class I and II epitopes of the M protein and myosin are related to group A streptococcal exposure in endemic populationsE R Brandt, P J Yarwood, D J McMillan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 8, 1997
Complete protective immunity induced in mice by immunization with the 19-kilodalton carboxyl-terminal fragment of the merozoite surface protein-1 (MSP1[19]) of Plasmodium yoelii expressed in Saccharomyces cerevisiae: correlation of protection with antigen-specific antibody titer, but not with effector CD4+ T cellsC Hirunpetcharat, J H Tian, D C Kaslow, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|September 1, 1990
Recognition of dominant T cell-stimulating epitopes from the circumsporozoite protein of Plasmodium falciparum and relationship to malaria morbidity in Gambian childrenE M Riley, S J Allen, S Bennett, et al.
Pageof 16